Venatorx Pharmaceuticals has completed a Series A financing round of approximately $3.5M from private investors to complement its other sources of funding and help advance its novel discovery and development programs.
Venatorx Pharmaceuticals has completed a Series A financing round of approximately $3.5M from private investors to complement its other sources of funding and help advance its novel discovery and development programs.
| You are using a browser that is not supported. Please consider changing your browser |